Joanna Phillips

Joanna Phillips

University of California, San Francisco

H-index: 74

North America-United States

About Joanna Phillips

Joanna Phillips, With an exceptional h-index of 74 and a recent h-index of 59 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Cancer biology, neuro-oncology, cell biology, tumor microenvironment.

His recent articles reflect a diverse array of research interests and contributions to the field:

Everolimus for children with recurrent or progressive low-grade glioma: Results from the phase II PNOC001 trial

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas

Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma

Role of the Microenvironment in Glioma Pathogenesis

Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

Joanna Phillips Information

University

Position

___

Citations(all)

23468

Citations(since 2020)

16718

Cited By

11104

hIndex(all)

74

hIndex(since 2020)

59

i10Index(all)

187

i10Index(since 2020)

167

Email

University Profile Page

University of California, San Francisco

Google Scholar

View Google Scholar Profile

Joanna Phillips Skills & Research Interests

Cancer biology

neuro-oncology

cell biology

tumor microenvironment

Top articles of Joanna Phillips

Title

Journal

Author(s)

Publication Date

Everolimus for children with recurrent or progressive low-grade glioma: Results from the phase II PNOC001 trial

Journal of Clinical Oncology

Daphne A Haas-Kogan

Mariam S Aboian

Jane E Minturn

Sarah ES Leary

Mohamed S Abdelbaki

...

2024/2/1

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

Acta Neuropathologica

Sara Hadad

Rohit Gupta

Nancy Ann Oberheim Bush

Jennie W Taylor

Javier E Villanueva-Meyer

...

2024/6

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas

Neuro-oncology

Atsuro Saijo

Hirokazu Ogino

Nicholas A Butowski

Meghan R Tedesco

David Gibson

...

2024/2/1

Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma

Modern Pathology

Sol Beccari

Esraa Mohamed

Viva Voong

Stephanie Hilz

Marisa Lafontaine

...

2024/4/6

Role of the Microenvironment in Glioma Pathogenesis

Maya Anjali Jayaram

Joanna J Phillips

2024/1/24

Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression

Neuro-oncology

Christina L Appin

Chibo Hong

Abigail K Suwala

Stephanie Hilz

Radhika Mathur

...

2024/4/1

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

Cell

Radhika Mathur

Qixuan Wang

Patrick G Schupp

Ana Nikolic

Stephanie Hilz

...

2024/1/18

Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

Cancer Research

Darwin Kwok

Nicholas O Stevers

Takahide Nejo

Lee H Chen

Inaki Etxeberria

...

2024/3/22

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

Scientific Reports

Takahide Nejo

Lin Wang

Kevin K Leung

Albert Wang

Senthilnath Lakshmanachetty

...

2024/3/16

PATH-08. LONGITUDINAL MOLECULAR EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA IN ADULTS

Neuro-Oncology

Calixto-Hope Lucas

Nadeem Al-Adli

Jacob Young

Ramin Morshed

Rohit Gupta

...

2023/11/1

NIMG-12. SPATIALLY MAPPING TREATMENT-EFFECT IN RECURRENT GLIOMA WITH PHYSIOLOGIC MRI AND DEEP LEARNING

Neuro-Oncology

Jacob Ellison

Nate Tran

Rany Hanna

Joanna Phillips

Anny Shai

...

2023/11/1

Abstract IA022: Cell archetypes in human brain metastases: Connecting programs in tumor cells with the microenvironment

Cancer Research

Hugo Gonzalez

Wenbin Mei

Isabella Robles

Catharina Hagerling

Breanna Allen

...

2023/1/15

Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma

Journal of Clinical Oncology

Shawn L Hervey-Jumper

Yalan Zhang

Joanna J Phillips

Ramin A Morshed

Jacob S Young

...

2023/4/10

Clarifying the Transcriptional Profiles of Malignant Clones through Multiscale and Multiomic Analysis of Individual Tumors

PG Schupp

SJ Shelton

DJ Brody

R Eliscu

BE Johnson

...

2023/6/22

CHAPTER II. TEMPOROSPATIAL GENOMIC PROFILING IN GLIOBLASTOMA IDENTIFIES COMMONLY ALTERED CORE PATHWAYS UNDERLYING TUMOR PROGRESSION

TARGETING RECURRENCE IN GLIOBLASTOMA

Mylan R Blomquist

Shannon Fortin Ensign

Fulvio D’Angelo

Joanna J Phillips

2023/8

EPCO-48. THE SINGLE-CELL AND SPATIAL TRANSCRIPTOMIC ARCHITECTURE OF MENINGEAL SOLITARY FIBROUS TUMORS PHENOCOPIES CEREBRAL VASCULAR DEVELOPMENT AND HOMEOSTASIS

Neuro-Oncology

Kanish Mirchia

Abrar Choudhury

Tara Joseph

Janeth Ochoa Birrueta

Joanna Phillips

...

2023/11/1

NIMG-22. COMPARISON OF NON-INVASIVE, ML-GENERATED WHOLE-BRAIN SPATIAL RADIOPATHOMIC MAPS DERIVED FROM ANATOMICAL AND DIFFUSION-WEIGHTED MRI ON PATIENTS WITH NEWLY DIAGNOSED-GLIOMA

Neuro-Oncology

Oluwaseun Adegbite

Nate Tran

Annette Molinaro

Joanna Phillips

Peter LaViolette

...

2023/11/1

N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

Cancer research

Duygu Kuzuoglu-Ozturk

Ozlem Aksoy

Christin Schmidt

Robin Lea

Jon D Larson

...

2023/1/4

Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies

Cancer Research

Darwin W Kwok

Michael Y Zhang

Cliff Wang

Nicholas Stevers

Tyler Borrman

...

2023/4/4

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors

The Journal of clinical investigation

Michael R Drumm

Wenxia Wang

Thomas K Sears

Kirsten Bell-Burdett

Rodrigo Javier

...

2023/6/15

See List of Professors in Joanna Phillips University(University of California, San Francisco)